Onco-miR-155 targets SHIP1 to promote TNFalpha-dependent growth of B cell lymphomas. [electronic resource]
- EMBO molecular medicine Aug 2009
- 288-95 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't